Brief: Piramal Pharma March-Quarter Consol Net PAT Rises
May 10 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* PIRAMAL PHARMA MARCH-QUARTER CONSOL NET PAT 1.01 BILLION
RUPEES
VERSUS PROFIT 501.1 MILLION RUPEES
* PIRAMAL PHARMA MARCH-QUARTER CONSOL REVENUE FROM
OPERATIONS
25.52 BILLION RUPEES VERSUS 21.64 BILLION RUPEES
Source text for Eikon: ID:
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio